Comments from TAG Pharmacy to FDA Draft Guidance Re: 503A

Comment from TAG Pharmacy

• Please see my attached letter which contains my comments.

• Public Submission
• Posted:
  02/06/2014
• ID:
  FDA-2013-D-1444-0014